Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Aeshah Alluli, Willem Rijnbout St. James, David H. Eidelman, Carolyn J. Baglole
Author Archives: ScienceDirect Publication: Biochemical Pharmacology
Functional assay for assessment of agonistic or antagonistic activity of angiotensin AT<sub>2</sub> receptor ligands reveals that EMA401 and PD123319 have agonistic properties
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): A. Augusto Peluso, Igor M. Souza-Silva, Daniel C. Villela, Pernille B.L. Hansen, Anders Hallberg, Michael Bader, Robson Santos, Colin Sumners, U. Muscha Steckelings
Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Stefano Mastrangelo, Alberto Romano, Giorgio Attinà, Palma Maurizi, Antonio Ruggiero
Sesamin ameliorates lipotoxicity and lipid accumulation through the activation of the estrogen receptor alpha signaling pathway
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Thi Hoa Pham, Gi Ho Lee, Sun Woo Jin, Seung Yeon Lee, Eun Hee Han, Nam Doo Kim, Chul Yung Choi, Gil-Saeng Jeong, Sang Ki Lee, Hyung Sik Kim, Hye Gwang Jeong
Febuxostat alleviates Arsenic Trioxide-Induced renal injury in Rats: Insights on the crosstalk between NLRP3/TLR4, Sirt-1/NF-κB/TGF-β signaling Pathways, and miR-23b-3p, miR-181a-5b expression
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Basel A. Abdel-Wahab, Ehab A.M. El-Shoura, Mohammed Shafiuddin Habeeb, Dalia Zafaar
The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Sean A. Piwarski, Travis B. Salisbury
Mechanisms of breast cancer progression induced by environment-polluting aryl hydrocarbon receptor agonists
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Noelia V. Miret, Carolina A. Pontillo, Sol Buján, Florencia A. Chiappini, Andrea S. Randi
Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells through the aryl hydrocarbon receptor
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Jonathan D. Diedrich, Romina Gonzalez-Pons, Hyllana C.D. Medeiros, Elliot Ensink, Karen T. Liby, Elizabeth A. Wellberg, Sophia Y. Lunt, Jamie J. Bernard
Lung cancer associated with combustion particles and fine particulate matter (PM<sub>2.5</sub>) – The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Jørn A. Holme, Jan Vondráček, Miroslav Machala, Dominique Lagadic-Gossmann, Christoph F.A. Vogel, Eric Le Ferrec, Lydie Sparfel, Johan Øvrevik
Aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) play both distinct and common roles in the regulation of colon homeostasis and intestinal carcinogenesis
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Gerardo Vázquez-Gómez, Jiří Petráš, Zdeněk Dvořák, Jan Vondráček